| http://www.w3.org/ns/prov#value | - One embodiment employs one or more hydrophobic polymers in combination with one or more bioactive agents???such as a pharmaceutical agent or other agents that aid in the treatment of aneurysmal tissue???such that the amount and rate of release of agent(s) can be controlled, e.g., by adjusting the relative types and/or concentrations of hydrophobic polymers in the mixture.
|
